Literature DB >> 27477636

Esophageal dysfunction in different stages of Parkinson's disease.

I Suttrup1, J Suttrup2, S Suntrup-Krueger1, M-L Siemer3, J Bauer3, C Hamacher1, S Oelenberg1, D Domagk3, R Dziewas1, T Warnecke1.   

Abstract

BACKGROUND: Dysphagia is a clinically relevant symptom in patients with Parkinson's disease (PD) leading to pronounced reduction in quality of life and other severe complications. Parkinson's disease-related dysphagia may affect the oral and pharyngeal, as well as the esophageal phase of swallowing.
METHODS: To examine the nature and extend of esophageal dysphagia in different stages of PD and their relation to oropharyngeal dysfunction, we examined 65 PD patients (mean age 66.3±9.7 years, mean disease duration 7.9±5.8 years, mean Hoehn & Yahr [H&Y] stage 2.89±0.91) and divided into three groups (early [H&Y I+II; n=21], intermediate [H&Y III; n=25], and advanced stadium [H&Y IV+V; n=19]), using esophageal high-resolution manometry (HRM) to detect esophageal motor disorders. Oropharyngeal impairment was assessed using fiberoptic endoscopic evaluation of swallowing. KEY
RESULTS: Major esophageal motor disorders were detected in nearly one third of the PD patients. Minor impairment of the esophageal body was present in 95% of participants and throughout all disease stages with pathological findings especially in peristalsis and intrabolus pressure (IBP). The IBP was found to significantly increase in the advanced stadium. Although dysfunction of the upper and lower esophageal sphincters was observed in individual patients, alterations in these esophageal segments revealed no statistical significance compared with normative data. No clear association was found between the occurrence of oropharyngeal dysphagia and esophageal impairment. CONCLUSIONS & INFERENCES: Esophageal body impairment in PD is a frequent phenomenon during all disease stages, which possibly reflects α-synucleinopathy in the enteric nervous system.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990FEESzzm321990; Parkinson's disease; esophageal dysphagia; high-resolution manometry

Mesh:

Year:  2016        PMID: 27477636     DOI: 10.1111/nmo.12915

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  7 in total

Review 1.  Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord       Date:  2018-03       Impact factor: 10.338

2.  Prevalence and Associated Impacts of Cervical Esophageal Clearance Issues Post Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC).

Authors:  Raymond Fong; Anna F Rumbach; Elizabeth C Ward
Journal:  Dysphagia       Date:  2019-04-15       Impact factor: 3.438

Review 3.  Parkinson's Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects.

Authors:  Chethan Ramprasad; Jane Yellowlees Douglas; Baharak Moshiree
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 4.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Casper Skjærbæk; Karoline Knudsen; Jacob Horsager; Per Borghammer
Journal:  J Clin Med       Date:  2021-01-31       Impact factor: 4.241

Review 5.  Management of dysphagia and gastroparesis in Parkinson's disease in real-world clinical practice - Balancing pharmacological and non-pharmacological approaches.

Authors:  Roongroj Bhidayasiri; Warongporn Phuenpathom; Ai Huey Tan; Valentina Leta; Saisamorn Phumphid; K Ray Chaudhuri; Pramod Kumar Pal
Journal:  Front Aging Neurosci       Date:  2022-08-11       Impact factor: 5.702

6.  Establishing gene regulatory networks from Parkinson's disease risk loci.

Authors:  Sophie L Farrow; William Schierding; Sreemol Gokuladhas; Evgeniia Golovina; Tayaza Fadason; Antony A Cooper; Justin M O'Sullivan
Journal:  Brain       Date:  2022-07-29       Impact factor: 15.255

7.  Subtle Esophageal Motility Alterations in Parkinsonian Syndromes: Synucleinopathies vs. Tauopathies.

Authors:  Inga Claus; Judith Suttrup; Paul Muhle; Sonja Suntrup-Krueger; Marie-Luise Siemer; Frank Lenze; Rainer Dziewas; Tobias Warnecke
Journal:  Mov Disord Clin Pract       Date:  2018-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.